基本信息
浏览量:229
职业迁徙
个人简介
He has experienced more than 400 cases of ERCP, more than 300/100 cases of EUS/EUS-FNA/B per year since 2003 and His research interests are development of novel therapy for advanced pancreatic cancer and cholangiocarcinoma and also identification of novel biomarkers (predictive or prognostic) related to early diagnosis or long-term outcome of pancreatic cancer and cholangiocarcinoma. Recently, he participates in global GWAS study of pancreatic cancer sponsored by NCI (Bethesda, USA) as one of core members. Moreover, he is conducting development of liquid-biopsy driven biomarkers (ctDNA/proteomic marker/immunologic marker) for early diagnosis and monitoring of pancreatic cancer or cholangiocarcinoma. Recently, he finished phase I clinical trial (adenovirus-medicated double suicide gene therapy) in locally advanced pancreatic cancer successfully and now recently started phase II clinical trial using the gene therapy for locally advanced pancreatic cancer at 2021. Another phase 1 trial in advanced pancreatic cancer using novel egent (PAUF-MoAb) will be started soon. He is also conducting development of predictive biomarker for chemotherapy in pancreatic cancer using cancer tissue by WES and WTS.
研究兴趣
论文共 382 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of Clinical Oncologyno. 16_suppl (2024): 4154-4154
In-Jun Hwang,Chanhee Choi,Hongwon Kim,Hyunji Lee, Yejoo Yoo, Yujin Choi,Jin-Hyeok Hwang,Kwangrok Jung,Jong-Chan Lee,Jong-Ho Kim
Dong Kee Jang,Young Ae Kim, Jang Won Lee, Hak-June Kim,Yoon Suk Lee,Jung Won Chun,Jong-Chan Lee,Sang Myung Woo,Jin-Hyeok Hwang
European journal of radiology (2024): 111516-111516
Gastroenterologyno. 6 (2023): S-599
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): e15168-e15168
openalex(2023)
Journal of clinical oncologyno. 4_suppl (2023): 739-739
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): e16291-e16291
加载更多
作者统计
#Papers: 379
#Citation: 5862
H-Index: 41
G-Index: 62
Sociability: 7
Diversity: 0
Activity: 2
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn